The CSIRO Biomedical Materials Facility (BMTF) specialises in the development of biomedical molecules, materials, coatings and devices and provides advanced cell-based biological validation to assist companies with rapid transition from R&D to pre-clinical evaluation. Located in Clayton (Melbourne) within CSIRO’s Biomedical Manufacturing Program and in close proximity with MedTech partners at Monash Biomedical Imaging (MBI, ISO 9001:2008) and the Monash Health Translational Precinct (MHTP, GMP ISO Class 8), the facility aims to foster rapid progress in three synergistic areas critical to the translation of biomedical materials research for medical device, drug delivery, diagnostics and cell therapies:
- Clean room materials synthesis, fabrication and surface coating.
- High throughput biological testing and evaluation of materials.
- Large animal models and real-time non-invasive imaging for pre-clinical studies.
Building on CSIRO’s expertise in polymers for medical devices as well as human cell technologies the BMTF, currently being developed to be operational under GLP (NATA ISO17025), is equipped to enable:
- Rapid advanced material discovery & processing https://www.csiro.au/en/Research/MF/Areas/Chemicals-and-fibres/RAMP
- Biomaterials synthesis, fabrication (including 3D bioprinting) and surface modification (ISO Class 7 cleanroom)
- Ceramic biomaterial preparations (High temperature furnace laboratory)
- High throughput multiplexed evaluation of biological responses in vitro (PC2 laboratory).